Role of Probiotics in acute diarrhea in children of age 6 months to 5 years.

Safety and Efficacy of saccharomyces boulardii (CNCM I-745) in acute diarrhea in children of age 6 months to 5 years.A Randomized Double blind controlled study. - RCT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061370

Enrollment

140

Registered

2024-01-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Saccharomyces boulardii (CNCM I-745) treated group: The amount,consistency and frequency of stool will analyzed for efficacy and adverse effects will be noted for safety those treated w

Eligibility

Inclusion criteria

Inclusion criteria: All the children age between 6 months to 5 years attending out patient department of Pediatrics with diagnosis of acute diarrhea.

Exclusion criteria

Exclusion criteria: History of presence of blood in stool,Clinical signs of severe malnutrition,Clinical signs of severe dehydration,Treatment with antibiotics/probiotics,Coexisting acute systemic illness

Design outcomes

Primary

Measure	Time frame
1.To evaluate safety and efficacy of saccharomyces boulardii in acute diarrhea in children of age 6 months to 5 years.Timepoint: On day 3 and day 6	—

Secondary

Measure	Time frame
To analyse other associated clinical features in acute diarrhea.Timepoint: on day 3 and day 6	—

Countries

India

Contacts

Public ContactDR SANJAY MANDOT

Geetanjali Medical College and Hospital

drmandot@yahoo.com9462022900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026